Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (281-290 of 570) with videos related to

Pageof 57
Sort By:
Cell Reports|November 3, 2021
mGlu<sub>1</sub> potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficitsJames Maksymetz, Nellie E Byun, Deborah J Luessen, et al.
Frontiers in Pharmacology|January 26, 2012
Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1Rene Raphemot, Daniel F Lonergan, Thuy T Nguyen, et al.
The Journal of Biological Chemistry|July 29, 2014
Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibitionThomas H Oguin, Shalini Sharma, Amanda D Stuart, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2020
Lead optimization of the VU0486321 series of mGlu<sub>1</sub> PAMs. Part 4: SAR reveals positive cooperativity across multiple mGlu receptor subtypes leading to subtype unselective PAMsDexter C Davis, Joseph D Bungard, Sichen Chang, et al.
Prostaglandins & Other Lipid Mediators|July 6, 2019
The effect of the EP3 antagonist DG-041 on male mice with diet-induced obesityRyan P Ceddia, Jason D Downey, Ryan D Morrison, et al.
Journal of Medicinal Chemistry|June 13, 2018
Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic AnalysisLaura Friggeri, Tatiana Y Hargrove, Zdzislaw Wawrzak, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2019
Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249Yuzo Iwaki, Kentaro Yashiro, Masaya Kokubo, et al.
ACS Chemical Neuroscience|April 24, 2010
Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput ScreeningRalf Mueller, Alice L Rodriguez, Eric S Dawson, et al.
Journal of Medicinal Chemistry|August 3, 2016
Development of a Series of (1-Benzyl-3-(6-methoxypyrimidin-3-yl)-5-(trifluoromethoxy)-1H-indol-2-yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists with in Vivo Utility and Activity Against γ-ThrombinKayla J Temple, Matthew T Duvernay, Summer E Young, et al.
Journal of Cell Science|May 26, 2011
PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophilsLaura J Norton, Qifeng Zhang, Khalid M Saqib, et al.
Pageof 57

Showing results (281-290 of 570) with videos related to

Sort By:
Pageof 57
Cell Reports|November 3, 2021
mGlu<sub>1</sub> potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficitsJames Maksymetz, Nellie E Byun, Deborah J Luessen, et al.
Frontiers in Pharmacology|January 26, 2012
Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1Rene Raphemot, Daniel F Lonergan, Thuy T Nguyen, et al.
The Journal of Biological Chemistry|July 29, 2014
Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibitionThomas H Oguin, Shalini Sharma, Amanda D Stuart, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2020
Lead optimization of the VU0486321 series of mGlu<sub>1</sub> PAMs. Part 4: SAR reveals positive cooperativity across multiple mGlu receptor subtypes leading to subtype unselective PAMsDexter C Davis, Joseph D Bungard, Sichen Chang, et al.
Prostaglandins & Other Lipid Mediators|July 6, 2019
The effect of the EP3 antagonist DG-041 on male mice with diet-induced obesityRyan P Ceddia, Jason D Downey, Ryan D Morrison, et al.
Journal of Medicinal Chemistry|June 13, 2018
Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic AnalysisLaura Friggeri, Tatiana Y Hargrove, Zdzislaw Wawrzak, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2019
Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249Yuzo Iwaki, Kentaro Yashiro, Masaya Kokubo, et al.
ACS Chemical Neuroscience|April 24, 2010
Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput ScreeningRalf Mueller, Alice L Rodriguez, Eric S Dawson, et al.
Journal of Medicinal Chemistry|August 3, 2016
Development of a Series of (1-Benzyl-3-(6-methoxypyrimidin-3-yl)-5-(trifluoromethoxy)-1H-indol-2-yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists with in Vivo Utility and Activity Against γ-ThrombinKayla J Temple, Matthew T Duvernay, Summer E Young, et al.
Journal of Cell Science|May 26, 2011
PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophilsLaura J Norton, Qifeng Zhang, Khalid M Saqib, et al.
Pageof 57